Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.54 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18469082 | 0.86 | GABRA1 (0.62) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL9579249 | 0.83 | GABRA1 (0.54) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL9734713 | 0.78 | GABRA1 (0.54) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL14498154 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL22699932 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL23995722 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL16956704 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL14498155 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL23447201 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 | |
| SCHEMBL16950672 | 0.77 | GABRA1 (0.52) | GABRA1GABRG2GABRB3CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116194552-A | Cyclic phosphazene compounds having oxaphosphaphenanthrene-containing ring structure | 株式会社伏见制药所 | 2023-05-30 | — | — | CN | disclosed |
| US-7767739-B2 | Cyanato group-containing cyclic phosphazene compound and method for producing the same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | CENPE, CPNE4, MCM3 | GABRA1 4017/4885GABRG2 3304/4885GABRB3 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.